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Stimulation of group I metabotropic glutamate receptors (mGluRs) initiates a wide vari-
ety of signaling pathways. Group I mGluR activation can regulate gene expression at both
translational and transcriptional levels, and induces translation or transcription-dependent
synaptic plastic changes in neurons. The group I mGluR-mediated translation-dependent
neural plasticity has been well reviewed. In this review, we will highlight group I mGluR-
induced gene transcription and its role in synaptic plasticity. The signaling pathways (PKA,
CaMKs, and MAPKs) which have been shown to link group I mGluRs to gene transcrip-
tion, the relevant transcription factors (CREB and NF-κB), and target proteins (FMRP and
ARC) will be documented. The significance and future direction for characterizing group I
mGluR-mediated gene transcription in fragile X syndrome, schizophrenia, drug addiction,
and other neurological disorders will also be discussed.
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INTRODUCTION
The metabotropic glutamate receptors (mGluRs) belong to family
C of G-protein coupled receptors (GPCRs) and are widely dis-
tributed throughout the central nervous system (CNS; Kim et al.,
2008; Niswender and Conn, 2010; Nicoletti et al., 2011). These
receptors are distinguished from family A of GPCRs by the pres-
ence of a large extracellular N-terminal domain that contains
the endogenous ligand binding site. The mGluRs bind gluta-
mate within a large extracellular domain and transmit signals
through the receptor protein to intracellular molecular partners,
and provide a mechanism by which glutamate modulates cell
excitability and synaptic transmission via second messenger sig-
naling pathways (Kim et al., 2008; Gladding et al., 2009). Eight
mGluR subtypes have been identified and are subclassified into
three groups based on sequence homology, G-protein coupling,
and ligand selectivity. Group I mGluRs (mGluR1 and mGluR5)
are predominantly coupled to the activation of phospholipase C
(PLC) via Gαq/11, whereas group II (mGluR2 and mGluR3) and
group III (mGluR4, mGluR6, mGluR7, and mGluR8) mGluRs
negatively regulate adenylyl cyclase via Gαi (Niswender and Conn,
2010; Nicoletti et al., 2011). These mGluR subtypes are differen-
tially localized in presynaptic and postsynaptic regions of neurons,
as well as in glial cells (Kim et al., 2008; Gladding et al., 2009;
Ribeiro et al., 2010).
The mGluRs can modulate diverse neuronal responses and their
downstream targets exist not only in the membrane but also in
the cytoplasm and nucleus (Heinke and Sandkuhler, 2005; Ger-
ber et al., 2007; Gladding et al., 2009). Group I mGluRs have
been shown to regulate gene expression at both translational and
transcriptional levels (Antar et al., 2004; Hou et al., 2006; Ger-
ber et al., 2007; Gladding et al., 2009). Previous studies have
provided insights into how mGluRs initiate signal transduction
and details about the signaling pathways downstream of these
receptors. The roles of group I mGluRs in protein synthesis have
been well documented (Bear et al., 2004; Garber et al., 2006; Hou
et al., 2006; Waung et al., 2008; Waung and Huber, 2009). Here,
we will focus on group I mGluR-mediated gene transcription and
its implications in synaptic plasticity. We will discuss how group I
mGluRs induce gene transcription and the significance of group I
mGluR-mediated gene transcription in neurological conditions.
GROUP I mGluR-MEDIATED GENE TRANSCRIPTION
GROUP I mGluR SIGNALING PATHWAYS
Group I mGluRs are primarily coupled to the activation of
Gαq/11 proteins which stimulate PLCβ, resulting in the cleav-
age of phosphatidylinositol-4,5-bisphosphate with the ensuing
formation of the intracellular second messengers, inositol-1,4,5-
trisphosphate (IP3), and diacylglycerol (DAG; Gladding et al.,
2009; Niswender and Conn, 2010; Nicoletti et al., 2011). Addition-
ally, group I mGluR activation facilitates L-type voltage dependent
Ca2+ channels (L-VDCCs) and induces Ca2+ influx through L-
VDCCs (Chavis et al., 1996; Mao and Wang, 2003b). The IP3
binding to its receptor leads to the release of Ca2+ from intracel-
lular stores; both Ca2+ and DAG activate protein kinase C (PKC);
PKC has been found to activate phospholipase D (PLD), phospho-
lipase A2 (PLA2), as well as to modulate a variety of ion channels
(Niswender and Conn, 2010; Nicoletti et al., 2011). It is known
that group I mGluRs can trigger additional signaling pathways
downstream of Gαq/11 as well as pathways stemming from Gαs
and Gαi/o, and other molecules independent of G-protein (Gerber
et al., 2007; Kim et al., 2008; Niswender and Conn, 2010). Depend-
ing on the neuronal populations, stimulating group I mGluRs
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can activate a wide range of protein kinase pathways, including
cAMP dependent protein kinase (PKA), Ca2+ calmodulin depen-
dent protein kinases (CaMKs), mitogen-activated protein kinases
(MAPKs), phosphoinositide 3-kinase (PI3K), mammalian target
of rapamycin (mTOR), p70 S6 kinase, casein kinase 1, and cyclin-
dependent protein kinase 5 (Liu et al., 2002; Harris et al., 2004;
Hou et al., 2006; Mao et al., 2008; Gladding et al., 2009; Niswen-
der and Conn, 2010; Ribeiro et al., 2010; Nicoletti et al., 2011).
These signaling pathways are believed to be particularly impor-
tant for the regulation of synaptic plasticity by group I mGluRs.
The PKA, CaMKs, MAPKs, and PI3K pathways have been shown
to link group I mGluRs to transcriptional changes in the nucleus
(O’Riordan et al., 2006; Gerber et al., 2007; Gladding et al., 2009;
see Figure 1 for the model).
PKA
The cAMP signaling pathway contributes to the activity-
dependent synaptic plasticity in the anterior cingulate cortex
(ACC; Wei et al., 2002b, 2006; Liauw et al., 2005; Zhuo, 2008).
Previous studies have shown that stimulating Group I mGluRs
potentiates cAMP accumulation in cultured striatal neurons, stria-
tum, and cerebral cortex (Cartmell et al., 1997, 1998; Schaffhauser
et al., 1997). We found that stimulating group I mGluRs with their
agonist (RS)-3, 5-Dihydroxyphenylglycine [(RS)-3, 5-DHPG],
increases the cAMP levels in cingulate cortical neurons (Wang
et al., 2008a). Both the intracellular calcium stores and external
calcium influx through L-VDCCs are required for cAMP produc-
tion following stimulation of Group I mGluRs. PKA is activated by
Group I mGluRs in ACC neurons (Wang et al., 2008a). Among the
cAMP signaling molecules, adenylyl cyclase 1 (AC1) and AC8, are
the two major Ca2+/calmodulin stimulated AC isoforms (Suna-
hara and Taussig, 2002; Wang and Storm, 2003; Cooper and
Crossthwaite, 2006; Wang et al., 2007a, 2011). We found that
AC1, but not AC8, plays a critical role in PKA signaling pathway
during group I mGluR activation in ACC neurons (Wang et al.,
2008a).
FIGURE 1 | Signaling pathways for group I mGluR-mediated gene
transcription. Stimulating group I mGluRs triggers Ca2+ release from
intracellular calcium stores by IP3 and Ca2+ influx from L-VDCCs through
membrane depolarization. Postsynaptic increases of Ca2+ lead to activation of
Ca2+-calmodulin (CaM) dependent pathways. Among them, AC1 and CaMKIV
are activated. AC1 activation leads to the generation of cAMP and cAMP then
activates PKA. PKA and CaMKIV phosphorylate CREB. ERK1/2 and p38 MAPK
are stimulated by G-protein release after mGluR1/5 activation through the
mitogen-activated protein kinase kinases MKK/MEK. JNK can be stimulated
by transactivation of EGFR by group I mGluRs. PI3K is also initiated by group I
mGluR activation. Stimulation of ERK1/2, p38 MAPK, JNK, and PI3K leads to
activation of the transcription factors Elk-1, CREB, activator protein-1 (AP-1),
c-Jun, and other NF-κB members such as c-Rel through RSK1 and mitogen
and MSK1. The upregulation of the targets such as FMRP, ARC, c-fos, Egr1,
and BDNF by these transcriptional factors, could contribute to the modulation
of synaptic plasticity in the forms of LTP and LTD.
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Similarly, group I mGluR agonists have been found to acti-
vate PKA in other brain region (Bandrowski et al., 2001). The
PKA signaling pathway is critically involved in the effect of group
I mGluRs on the state of phosphorylation of GluA1 subunit of
the AMPA glutamate receptors (Dell’anno et al., 2012). In amyg-
dala, mGluR5 has been shown to activate PKA signaling pathway
through IP3 and reactive oxygen species (ROS; Li et al., 2011).
CaMKs
CaMKIV is a key effector in neuronal Ca2+ signaling and func-
tions as a transcriptional activator (Ho et al., 2000; Hook and
Means, 2001; Wei et al., 2002a; Colomer and Means, 2007; Way-
man et al., 2008, 2011). It is expressed in both nuclei and cytosol
of neurons in different brain regions, including cortex, striatum,
hippocampus, amygdale, and cerebellum (Colomer and Means,
2007; Wayman et al., 2008, 2011). CaMKIV has been implicated in
many aspects of neuronal Ca2+ signaling, including gene expres-
sion in response to excitatory neurotransmission (Colomer and
Means, 2007; Wayman et al., 2011). We found that stimulating
group I mGluRs activates CaMKIV in the ACC neurons (Wang
et al., 2009a). Both Ca2+ release from intracellular stores and Ca2+
influx through L-VDCCs are involved in the activation of CaMKIV
by group I mGluRs in ACC neurons (Wang et al., 2009a). Our study
thus suggests that CaMKIV may act as a downstream effector for
Group I mGluRs in ACC neurons. In cultured striatal neurons,
activation of both cell Surface and intracellular mGluR5 increases
phosphorylation of CaMKIV (Jong et al., 2009; Kumar et al., 2012).
Another member of the CaMKs family, CaMKII, is also well
known for its roles in gene transcription, synaptic plasticity, learn-
ing, and memory (Wayman et al., 2008, 2011; Mockett et al., 2011).
DHPG can cause a transient increase in CaMKII phosphorylation
in synaptoneurosomes prepared from whole hippocampus and in
CA1 slices (Mockett et al., 2011). In striatal neurons, activation
of intracellular mGluR5 increases phosphorylated CaMKII (Jong
et al., 2009; Kumar et al., 2012). These findings may implicate
CaMKII in group I mGluR-mediated gene transcription.
MAPKs
Mitogen-activated protein kinases are a family of serine/threonine
protein kinases, including extracellular signal regulated kinases
(ERKs), p38 MAPKs, and c-Jun N-terminal kinase (JNK; Davis
and Laroche, 2006; Wang et al., 2007b). It has been demon-
strated that stimulation of Group I mGluRs activates all these three
subclasses. The group I mGluRs actively regulate the phosphory-
lation of MAPKs (Niswender and Conn, 2010; Ribeiro et al., 2010;
Nicoletti et al., 2011). DHPG can induce the phosphorylation of
ERK1/2 in striatal neurons in vivo and in cultures (Mao et al., 2005,
2008). This effect was mediated partially by the conventional group
I mGluR signaling pathway since the PLC inhibitor and Ca2+
depleting agents or Ca2+ chelators reduced DHPG-induced phos-
phorylation of ERK1/2 (Mao et al., 2005). ERK signaling has been
found to be involved in chemical mGluR1-mediated late long-
term potentiation (LTP) at excitatory synapses onto hippocampal
interneurons in oriens-alveus (OA-INs), suggesting stimulating
mGluR1 may activate ERK (Ran et al., 2009, 2012). ERK activa-
tion may be triggered by mGluR5 activation by a cascade involving
the repressor activator protein 1 (Rap1) and mitogen-activated
protein/ERK kinase (MEK; Morozov et al., 2003). In amygdala,
ERK may be activated by mGluR5 through IP3 and ROS (Li et al.,
2011). Stimulating group I mGluR activates ERK in hippocampus
(Hou et al., 2006; O’Riordan et al., 2006). The activation of ERK2
requires PI3K and PKC; Both PI3K and PKC can cause ERK2 acti-
vation through Ras signaling pathway and its downstream target
MEK, the kinase responsible for activation of ERK (O’Riordan
et al., 2006). Group I mGluR-mediated signaling also activates
p38 MAPK, whereas DHPG-induced activation of p38 MAPK is
independent of PI3K and PKC (Huang et al., 2004; O’Riordan
et al., 2006). It has been shown that stimulating mGluR5 can acti-
vate p38 MAPK through Rap1 and MAPK kinase 3/6 (MKK3/6;
Huang et al., 2004).
In cultured striatal neurons, activation of both cell Surface and
intracellular mGluR5 increases phosphorylation of JNK (Kumar
et al., 2012). Stimulating group I mGluRs with DHPG induces the
phosphorylation of JNK through a signaling mechanism involv-
ing mGluR5-associated transactivation of the epidermal growth
factor receptor (EGFR), whereas the conventional signaling path-
ways (IP3 mediated Ca2+ release and PKC) are not involved in
this process (Yang et al., 2006). Interestingly, the scaffolding pro-
tein Homer1b/c may couple mGluR5 to ERK signaling cascade in a
Ca2+ independent manner (Mao et al., 2005). In addition, another
scaffolding protein, caveolin-1, an adaptor protein that associates
with lipid rafts and the main protein of caveolae, interacts with
group I mGluRs and regulates mGluR-dependent phosphoryla-
tion/activation of MAPKs (Francesconi et al., 2009). The studies
summarized here demonstrate that group I mGluRs are tightly
linked to MAPK signaling pathway.
The group I mGluRs are not only involved in gene transcrip-
tion, but also contribute to other aspects of gene expression at
the post-transcriptional and translational levels (Gerber et al.,
2007; Gladding et al., 2009; Nicoletti et al., 2011). It could be
argued that PKA, CaMKs, and MAPKs are involved in molec-
ular/cellular processes other than gene transcription. However,
our previous studies have provided clear evidence that PKA and
CaMKIV are involved in group I mGluR-mediated gene transcrip-
tion (Wang et al., 2008a, 2009a). The MAPK and PI3K signaling
pathways have also been shown to modulate gene transcription
through transcription factors by other studies (Gerber et al., 2007;
Gass and Olive, 2008; Gladding et al., 2009). The fact that the
same signaling pathways could be involved in different molec-
ular/cellular processes further reveals the complexity of group
I mGluR-mediated signaling network and the diverse functions
of mGluRs.
TRANSCRIPTION FACTORS
CREB
The cyclic AMP responsive element binding protein (CREB) is a
transcription factor that plays important roles in synaptic plastic-
ity (Kornhauser et al., 2002; Lonze and Ginty, 2002; Josselyn and
Nguyen, 2005; Zhuo, 2005; Suzuki et al., 2011; Kandel, 2012). The
activity of CREB is regulated by its phosphorylation. Phosphory-
lated CREB binds to the CRE site within the gene and activates
the gene transcription (Kornhauser et al., 2002; Lonze and Ginty,
2002; Kandel, 2012). We have demonstrated that group I mGluR
activation induce the phosphorylation of CREB in ACC neurons
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(Wang et al., 2008a). AC1 is involved in this process through PKA.
CaMKIV is another key molecule that phosphorylates CREB dur-
ing group I mGluR activation in ACC neurons (Wang et al., 2008a,
2009a).
In striatal neurons, mGluR5 activation induces CREB phos-
phorylation (Choe and Wang, 2002; Mao and Wang, 2003b; Mao
et al., 2008). In hippocampal interneurons, induction of mGluR1-
mediated late LTP has been found to stimulate CREB phospho-
rylation via ERK signaling (Ran et al., 2012), suggesting group
I mGluR-induced CREB activation can occur in different brain
areas.
NF-κB
The nuclear factor κB (NF-κB) family of dimeric transcription
factors plays a role in the induction of synaptic plasticity and for-
mation of long-term memory (Sheridan et al., 2007; Ahn et al.,
2008; Bracchi-Ricard et al., 2008; Boersma et al., 2011). NF-κB
subcellular distribution, DNA binding activity, and transcription
are regulated by various forms of synaptic activity (Memet, 2006;
O’Mahony et al., 2006; Romano et al., 2006). Moreover, regula-
tion of gene expression by group I mGluRs in cortical neurons
requires the activation of NF-κB factor c-Rel (Pizzi et al., 2005),
suggesting that NF-κB could be involved in the induction of
transcription-dependent forms of synaptic plasticity in the ner-
vous system, including long-term depression (LTD; Pizzi et al.,
2005). NF-κB is activated by group I mGluRs in hippocampus
(O’Riordan et al., 2006). The DNA binding activity of NF-κB fam-
ily members, such as p50, p65, and c-Rel, is increased in response to
group I mGluR signaling (O’Riordan et al., 2006). The mGluR5,
but not mGluR1, is involved in this activation. The PI3K, PKC,
MKK, and p38 MAPK signaling pathways are necessary for group
I mGluR-induced activation of NF-κB (O’Riordan et al., 2006). In
glial cells, glutamate activates NF-κB through mGluR5. The reg-
ulation of NF-κB requires Ca2+ and cross coupled signaling with
EGFR (Sitcheran et al., 2008). These findings reveal the diversity
of signaling pathways that modulate NF-κB activity and indicate
the importance of cross talks among different classes of receptors
to regulate gene expression.
Other transcription factors
In striatal neurons, mGluR5-mediated JNK activation can induce
the phosphorylation of c-Jun. The phosphorylated c-Jun then
leads to activation of the transcription factor activator protein-1
(AP-1) to facilitate target gene expression (Yang et al., 2006). Acti-
vation of mGluR5 induced a rapid and transient phosphorylation
of the transcription regulator Elk-1 in cultured striatal neurons.
Elk-1 phosphorylation was mediated through selective activation
of mGluR5 regulated PLC and IP3-sensitive Ca2+ release (Mao
and Wang, 2003a). ERK signaling targets multiple transcription
control pathways in addition to CREB. ERK targets both Elk-1 and
CREB in LTP-dependent transcription in dentate gyrus (Davis and
Laroche, 2006; Gladding et al., 2009). Stimulation of MAPKs and
PI3K leads to activation of the transcription factors Elk-1, CREB,
AP-1, c-Jun, and NF-κB through p90 ribosomal S6 kinase 1 (RSK1)
and mitogen and stress-activated protein kinase 1(MSK1; Arthur
et al., 2004; Hauge and Frodin, 2006; Gladding et al., 2009; Pearce
et al., 2010).
TARGET GENE EXPRESSION
FMRP
Fragile X mental retardation protein (FMRP), an mRNA binding
protein, regulates local protein synthesis at synapses and is involved
in activity-dependent synaptic plasticity (Bassell and Warren,
2008; Wang et al., 2008b, 2010, 2012b; Bhakar et al., 2012). The lack
of FMRP due to mutations in its encoding gene FMR1 can cause
fragile X syndrome, the most common form of inherited mental
retardation and autism spectrum disorders (Bear et al., 2004; Gar-
ber et al., 2006; Bassell and Warren, 2008; Rooms and Kooy, 2011;
Bhakar et al., 2012; Wang et al., 2012b). Previous studies showed
that the group I mGluR agonist DHPG induces the increase of
FMRP in a translation-dependent manner, and the induction
depends on the activation of mGluR5, rather than mGluR1 in
hippocampus (Antar et al., 2004; Hou et al., 2006; Bhakar et al.,
2012). We found that upregulation of FMRP by group I mGluRs
occurs at the transcriptional level in cingulate cortex (Wang et al.,
2008a). In addition, the upregulation of FMRP depends on the
activation of both mGluR1 and mGluR5 in ACC neurons (Wang
et al., 2008a). The differences in our findings from others’ could be
explained by the different composition of neuronal types between
hippocampus and cingulate cortex. Alternatively, the differences
might reflect the possible functional diversity of group I mGluRs
in different brain areas. We further demonstrated that CREB is
involved in the upregulation of FMRP by group I mGluRs in ACC
neurons (Wang et al., 2008a, 2009a). The regulation of FMRP by
group I mGluRs requires AC1 and CaMKIV; AC1 and CAMKIV
contribute to FMRP upregulation through CREB activation (Wang
et al., 2008a, 2009a). By using the transgenic mice overexpressing
dominant active CREB (Y134F) mutant which displays a higher
affinity with cAMP dependent kinase (PKA) compared to wild-
type CREB (Suzuki et al., 2011), we recently demonstrated that
upregulation of FMRP by stimulating group I mGluRs was further
enhanced in ACC neurons from these transgenic mice, provid-
ing further evidence that FMRP upregulation by group I mGluRs
involves CREB (Wang et al., 2012a). Our studies thus indicate that
FMRP can be transcriptionally regulated by group I mGluRs, and
CREB is the key transcription factor in group I mGluR-induced
FMRP upregulation in cingulate cortex (Figure 1).
ARC
Activity-regulated cytoskeleton-associated protein (Arc), also
known as activity-regulated gene 3.1 (Arg3.1), is an immediate
early gene that links gene expression changes with localized synap-
tic changes (Bramham et al., 2008; Alberi et al., 2011; Beique
et al., 2011; Korb and Finkbeiner, 2011; Shepherd and Bear, 2011;
Okuno et al., 2012). The expression of Arc is tightly coupled to
synaptic activities (Alberi et al., 2011; Beique et al., 2011; Korb
and Finkbeiner, 2011; Shepherd and Bear, 2011). Previous studies
have shown the functional relevance of Arc translation in mGluR-
dependent LTD in hippocampus (Alberi et al., 2011; Beique et al.,
2011; Korb and Finkbeiner, 2011; Shepherd and Bear, 2011). The
group I mGluR agonist DHPG can increase dendritic ARC protein
levels in a translation-dependent manner (Park et al., 2008; Waung
et al., 2008). An increase in Arc transcription was also observed
20 min following DHPG application (Park et al., 2008), suggesting
that following rapid translation of Arc, Arc can be upregulated at
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the transcriptional level. In hippocampal neurons cultured within
microfluidic chambers, DHPG applied to synaptic regions is suf-
ficient to signal to the nucleus and increase Arc transcription. The
increase in Arc mRNA was from new transcription since it can be
blocked by the transcription inhibitor Actinomycin D. Interest-
ingly, these newly transcribed Arc mRNAs caused by local group
I mGluR activation can be delivered to the region of synaptic
stimulation (Taylor et al., 2010). This study indicates that group
I mGluR activation can prompt a synapse-to-nucleus-to-synapse
signaling pathway. In cultured cortical neurons, it has also been
demonstrated that activation of group I mGluRs by DHPG can
induce transcription-dependent expression of ARC. The DHPG-
induced ARC upregulation requires CaMK, PLC, and ERK1/2
activity. Among these signaling molecules, ERK1/2 plays the cen-
tral role in group I mGluR-mediatedArc transcription (Wang et al.,
2009b).
Other immediate early genes
The transcription of the immediate early genes c-fos and egr1 is
dependent on CREB activity (Impey and Goodman, 2001; Korn-
hauser et al., 2002; Lonze and Ginty, 2002; Josselyn and Nguyen,
2005; Zhuo, 2005; Kandel, 2012). The mGluR5 stimulation upreg-
ulates c-fos and egr1 in striatal neurons (Mao and Wang, 2003b,c;
Jong et al., 2009). The induction of immediate early genes kineti-
cally corresponds to Elk-1 phosphorylation (Jong et al., 2009) and
can be attenuated by selectively knockdown of Elk-1 (Choe and
Wang, 2001; Mao and Wang, 2003a).
GROUP I mGluR-MEDIATED GENE TRANSCRIPTION AND
SYNAPTIC PLASTICITY
Activation of mGluRs results in diverse actions on neuronal
excitability and synaptic transmission by modulation of a vari-
ety of ion channels and other regulatory or signaling proteins
(Niswender and Conn, 2010; Ribeiro et al., 2010; Nicoletti et al.,
2011). Group I mGluRs are usually localized postsynaptically, and
their activation can lead to cell depolarization and increases in
neuronal excitability. Group I mGluRs play important roles in
induction or maintenance of long lasting forms of synaptic plas-
ticity, including LTD and LTP of transmission at glutamatergic
synapses (Huber et al., 2000; Huemmeke et al., 2002; Bear et al.,
2004; Heinke and Sandkuhler, 2005; Nosyreva and Huber, 2006;
Anwyl, 2009; Gladding et al., 2009; Nicoletti et al., 2011).
The mGluR-LTD involves not only the dendritic synthesis of
target proteins such as FMRP, ARC, postsynaptic density (PSD)
95, microtubule-associated protein 1B (MAP1B), and striatal-
enriched tyrosine phosphatase (STEP), but also the modulation of
transcription factors such as NF-κB, Elk-1, and CREB (Gladding
et al., 2009). NF-κB is a transcription factor that is activated in
mGluR-LTD (O’Riordan et al., 2006). The NF-κB family member
c-Rel has been shown to be necessary for long-term maintenance
of hippocampal mGluR-LTD (O’Riordan et al., 2006; Ahn et al.,
2008). This is inconsistent with previous studies which have shown
that mGluR-LTD involves translational rather than transcrip-
tional regulation. The explanation could be that synaptic changes
were monitored by previous studies at an early phase (<90 min)
rather than at a late phase (2∼3 h) of LTD (Huber et al., 2000;
O’Riordan et al., 2006). The inconsistency may also indicate that
the early phase of mGluR-LTD depends on dendritic translation of
pre-existing mRNA, whereas the late phase mGluR-LTD requires
new transcription. NF-κB can be synaptically localized and upon
synaptic activation is rapidly trafficked from the synapses to the
nucleus (Memet, 2006; Romano et al., 2006). In the stabilization of
mGluR-LTD, NF-κB may act as a signal messenger to facilitate the
expression of specific genes which are required for maintenance
of synaptic activity (O’Riordan et al., 2006).
The long-term synaptic plasticity in hippocampal inhibitory
interneurons plays important roles in learning and memory (Bar-
tos et al., 2007; Kullmann and Lamsa, 2007). Activation of mGluR1
at excitatory synapses onto hippocampal interneurons in oriens-
alveus can induce a transcription and translation-dependent form
of LTP which persists for at least 24 h (Ran et al., 2009). CREB
knockdown impaired this mGluR1-mediated chemical late LTP,
whereas CREB overexpression facilitated the induction, indicat-
ing that CREB-dependent transcription is a necessary permis-
sive switch for eliciting persistent presynaptic and postsynaptic
changes at excitatory synapses in inhibitory local circuits (Ran
et al., 2012). The CREB-dependent transcription may eventu-
ally enhance transmitter release and increases channel conduc-
tance and number of functional postsynaptic receptors during
maintenance of interneuron persistent synaptic plasticity.
IMPLICATIONS IN NEUROLOGICAL DISORDERS
A large body of studies have implicated group I mGluRs in the
pathogenesis of multiple neurological disorders, including fragile
X syndrome, schizophrenia, drug addiction, chronic pain, neu-
rodegenerative diseases, and other neurological disorders (Gravius
et al., 2010; Ribeiro et al., 2011; Bellone and Mameli, 2012; Bhakar
et al., 2012; Brown et al., 2012; Chiechio and Nicoletti, 2012; Dun-
can and Lawrence, 2012; Wang et al., 2012b). Targeting individual
mGluR subtypes has also shown promising outcomes for treat-
ment of some neurological and psychiatric disorders (Spooren
et al., 2010; Gregory et al., 2011; Gross et al., 2012). However,
group I mGluR signaling alterations in many of these disorders
still need to be further investigated.
The mGluR-mediated LTD is, under certain circumstances,
dependent on protein synthesis occurring as a result of local
mRNA translation. In the absence of FMRP, LTD associated pro-
teins are constitutively and highly expressed, and this makes a
selective amplification of mGluR5 mediated LTD in the hippocam-
pus of Fmr1 knockout (KO) mice, an animal model of fragile
X syndrome (Huber et al., 2000; Bear et al., 2004; Waung and
Huber, 2009; Krueger et al., 2011). The transcriptional regulation
of gene expression is also required for long-term maintenance of
hippocampal LTD and induction of mGluR-mediated late LTP
(Memet, 2006; Ran et al., 2012). However, little is known about
the gene transcription-dependent mGluR-mediated LTP or LTD in
fragile X syndrome. Our previous studies have shown the deficits
in LTP in both cingulate cortex and hippocampus of Fmr1 KO
mice (Zhao et al., 2005; Shang et al., 2009). The glycine induced
LTP depends on group I mGluRs and is deficient in hippocampus
of Fmr1 KO mice, whereas the function of group I mGluRs is not
affected in these mice (Wang et al., 2008a; Shang et al., 2009). Since
we have demonstrated that stimulating group I mGluRs upregu-
lates FMRP through CREB (Wang et al., 2008a, 2009a, 2012a), it is
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likely that the downstream effect of this signaling pathway (group I
mGluRs-CREB-FMRP) will be affected when FMRP is absent and
thus cause alterations in synaptic responses in fragile X syndrome.
Besides FMRP, many other effectors in signaling pathway of
group I mGluR-mediated gene transcription, such as CREB, NF-
κB,ARC,and c-fos,have been shown to be involved in chronic pain,
drug addiction, neurodegenerative diseases, and psychiatric disor-
ders (Zhuo, 2005; Memet, 2006; Korb and Finkbeiner, 2011; Kan-
del, 2012). Despite the fact that the functions of these downstream
effectors of mGluRs in learning, memory, and synaptic plasticity
have been well documented, future research is definitely needed
to characterize group I mGluR-mediated gene transcription in
neurological and psychiatric disorders.
CONCLUSION
Our understanding of mGluRs has greatly advanced in the past
decade. Previous studies regarding the function of group I mGluRs
have contributed to the knowledge about group I mGluRs in
modulation of neural plasticity and therapeutic perspectives of
these receptors in neurological disorders. The group I mGluRs
are not only involved in protein synthesis in cytoplasm, but
also in gene transcription in nucleus. Although group I mGluR
signaling pathways are becoming characterized, data on how
the mGluR signaling pathways can affect disease development
remains limited for most neurological diseases. An important
focus of future studies will be the linking of molecular data on
group I mGluRs with specific neural and behavioral functions
in both physiological and neurological conditions. We hope that
the future studies will continue to enhance our understanding
of the diverse neuronal mechanisms of mGluRs and will open
up new avenues for treatments of neurological and psychiatric
disorders.
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